CrD-related dysplasia characteristically shows p53 overexpression at a high rate (47–59%), in keeping with the frequent detection of TP53 mutations in CrD-associated small bowel adenocarcinomas [8,11,113,117]. This evidence concerns the gene TP53 and small intestine adenocarcinoma.